广发纳斯达克生物科技美元(001093)
动态评分： 5.90分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | IGMS | IGM Biosciences Inc | 3.14 | 0.02% |
| 2024-12-31 | FDMT | 4D Molecular Therapeutics Inc | 3.89 | 0.02% |
| 2024-12-31 | VNDA | Vanda Pharmaceuticals Inc | 4.21 | 0.02% |
| 2024-12-31 | ACRV | Acrivon Therapeutics Inc | 2.83 | 0.02% |
| 2024-12-31 | ACIU | AC Immune SA | 4.03 | 0.02% |
| 2024-12-31 | ARTV | Artiva Biotherapeutics Inc | 3.7 | 0.02% |
| 2024-12-31 | CCCC | C4 Therapeutics Inc | 3.84 | 0.02% |
| 2024-12-31 | FATE | Fate Therapeutics Inc | 2.84 | 0.02% |
| 2024-12-31 | LRMR | Larimar Therapeutics Inc | 3.73 | 0.02% |
| 2024-12-31 | AMLX | Amylyx Pharmaceuticals Inc | 3.91 | 0.02% |
| 2024-12-31 | CMPS | COMPASS Pathways plc ADR | 2.9 | 0.02% |
| 2024-12-31 | MGNX | MacroGenics Inc | 3.08 | 0.02% |
| 2024-12-31 | FHTX | Foghorn Therapeutics Inc | 3.96 | 0.02% |
| 2024-12-31 | ITOS | iTeos Therapeutics Inc | 4.23 | 0.02% |
| 2024-12-31 | INZY | Inozyme Pharma Inc | 2.69 | 0.02% |
| 2024-12-31 | NKTX | Nkarta Inc | 2.65 | 0.02% |
| 2024-12-31 | MRSN | 梅莎娜制药 | 2.67 | 0.02% |
| 2024-12-31 | EDIT | Editas Medicine Inc | 1.67 | 0.01% |
| 2024-12-31 | BMEA | Biomea Fusion Inc | 2.19 | 0.01% |
| 2024-12-31 | TCRX | TScan Therapeutics Inc | 2.25 | 0.01% |
公告&资料
